CA Patent
CA2755268A1 — Erbb inhibitors
Assigned to Array Biopharma Inc · Expires 2007-05-24 · 19y expired
What this patent protects
The invention provides compounds and process related thereto as follows: (see scheme 3)
USPTO Abstract
The invention provides compounds and process related thereto as follows: (see scheme 3)
Drugs covered by this patent
- Hernexeos (ZONGERTINIB) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.